4

Ushbu maqolada5-(p-aminofenil)-4-amino-1,2,4-triazol-3(2H)-tionkam zaharli sinfga mansub ekanligi, 0.1; 0.5; 1.0; 5.0 va 10.0 mg/kg dozalardapsixofarmakologik faolliklari va tutqanoqqa qarshi solishtirma preparatlar karbamazepin va konvuleksdan qolishmasligi eksperimental tajribalar asosida tasdiqlangan

  • Ўқишлар сони 4
  • Нашр санаси 06-04-2025
  • Мақола тилиO'zbek
  • Саҳифалар сони110-118
Ўзбек

Ushbu maqolada5-(p-aminofenil)-4-amino-1,2,4-triazol-3(2H)-tionkam zaharli sinfga mansub ekanligi, 0.1; 0.5; 1.0; 5.0 va 10.0 mg/kg dozalardapsixofarmakologik faolliklari va tutqanoqqa qarshi solishtirma preparatlar karbamazepin va konvuleksdan qolishmasligi eksperimental tajribalar asosida tasdiqlangan

№ Ҳавола номи
1 1.Strine TW, Kobau R, Chapman DP, Thurman DJ, Price P, BalluzLS. Psychological distress comorbidities andhealth behaviorsamong U.S. adults with seizures: results from the 2002 NationalHealth Interview Survey. Epilepsia. 2005 Jul;46(7):1133-9. doi:10.1111/j.1528-1167.2005.01605.x, PMID 16026567.2.Ashhar MU, Ahmad MZ, Jain V, Agarwal NB, Ahmad FJ, Jain GK.Intranasal pitavastatin attenuates seizures in differentexperimental models of epilepsy in mice. Epilepsy Behav. 2017Oct 1;75:56-9. doi: 10.1016/j.yebeh.2017.07.004, PMID28826009.3.Soares DA Silva P, Pires N, Bonifacio MJ, Loureiro AI, Palma N,Wright LC. Eslicarbazepine acetate for the treatment of focalepilepsy: an update on its proposed mechanisms of action. Pharmacol Res Perspect. 2015 Mar;3(2):e00124. Doi:10.1002/prp2.124, PMID 260387004.Hanada T. The discovery and development of perampanel forthe treatment of epilepsy. Expert Opin Drug Discov. 2014 Apr1;9(4):449-58. doi: 10.1517/17460441.2014.891580, PMID 24559052.5.Large CH, Sokal DM, Nehlig A, Gunthorpe MJ, Sankar R, Crean CS.The spectrum of anticonvulsant efficacy of retigabine(ezogabine) in animal models: implications for clinical use.Epilepsia. 2012 Mar;53(3):425-36. doi: 10.1111/j.1528-1167.2011.03364.x, PMID 22221318.6.Kamboj VK, Verma PK, Dhanda A, Ranjan S. 1,2,4-triazolederivatives as a potential scaffold for anticonvulsant activity.Cent Nerv Syst Agents Med Chem. 2015 Apr 1;15(1):17-22. doi:10.2174/1871524915666150209100533, PMID 25675400.7.Ben Menachem E. Medical management of refractory epilepsypractical treatment with novel antiepileptic drugs. Epilepsia. 2014Jan;55 Suppl 1:3-8. doi: 10.1111/epi.12494, PMID 24400690.8.Luszczki JJ,Plech T, Wujec M. Effect of 4-(4-bromophenyl)-5-(3-chlorophenyl)-2,4-dihydro-3H-1,2,4-triazole-3-thione on theanticonvulsant action of different classical antiepileptic drugs inthe mouse maximal electroshock induced seizure model. Eur JPharmacol. 2012Sep 5;690(1-3):99-106. doi:10.1016/j.ejphar.2012.06.023, PMID 22732650.9.Loring DW, Meador KJ. Cognitive side effects of antiepilepticdrugs in children. Neurology. 2004 Mar 23;62(6):872-7. doi:10.1212/01.wnl.0000115653.82763.07, PMID 15037684.10.Chen B, Choi H, Hirsch LJ, Katz A, Legge A, Buchsbaum R.Psychiatric and behavioral side effects of antiepileptic drugs inadults with epilepsy. Epilepsy Behav. 2017 Nov 1;76:24-31. doi:10.1016/j.yebeh.2017.08.039, PMID 28931473.11.Deka D, Chakravarty PI, Purkayastha AY. Evaluation of theanticonvulsant effect of aqueous extract of Centella asiatica inalbino mice. Int J Pharm Pharm Sci. 2017;9(2):312-4. doi:10.22159/ijpps.2017v9i2.15483.12.Karakucuk Iyidogan A, Basaran E, Tatar Yilmaz G, Oruc Emre EE.Development of new chiral 1,2,4-triazole-3-thiones and 1,3,4-thiadiazoles with promising in vivo anticonvulsant activitytargeting GABAergic system and voltage-gated sodium channels(VGSCs). Bioorg Chem. 2024 Oct 1;151:107662. doi:10.1016/j.bioorg.2024.107662, PMID 39079390.13.Rani S, Teotia S, Nain S. Recent advancements and biologicalactivities of triazole derivatives: a short review. Pharm Chem J.2024 Apr 15;57(12):1909-17. doi: 10.1007/s11094-024-03096-z.14.Mula M. GABAergic drugs in the treatment of epilepsy: modernor outmoded? Future Med Chem. 2011 Feb;3(2):177-82. doi:10.4155/fmc.10.296, PMID 21428812.15.Froestl W. An historical perspective on GABAergic drugs. FutureMed Chem. 2011 Feb;3(2):163-75. doi: 10.4155/fmc.10.285,PMID 21428811.16.Plech T, Luszczki JJ, Wujec M, Flieger J, Pizon M. Synthesischaracterization and preliminary anticonvulsant evaluation ofsome 4-alkyl-1,2,4-triazoles. Eur J Med Chem. 2013 Feb1;60:208-15. doi: 10.1016/j.ejmech.2012.11.026, PMID23291122.17.Sanoev Z.I., Ismailova D.S., Rakhimboev S.D., Tolibovich T.T., Elmuradov B.J., Abdinazarov I.T., Rashidov S.Z. (2023). Synthesis And Research Anticonvulsant Activity Of Annulated Triazolo-thiadiazine Derivative In Laboratory Animals. Biomedical & Pharmacology Journal. Vol. 16(4), p. 2457-2467.18.MatinMM, Matin P, Rahman MR, Ben Hadda T, Almalki FA,Mahmud S. Triazoles and their derivatives: chemistry synthesisand therapeutic applications. Front Mol Biosci. 2022 Apr25;9:864286. doi: 10.3389/fmolb.2022.864286, PMID35547394, PMCID PMC9081720.19.Zhang Y,Wang M, Ahmed M, HE L, JI M, QI Z. Synthesis fungicidalactivity and SAR of 3,4-dichloroisothiazole based cycloalkylsulfonamides. Bioorg Med Chem Lett. 2019 Jun 1;29(11):1345-9.doi: 10.1016/j.bmcl.2019.03.047, PMID 30956010.20.Zhang Y, Wang M, Ahmed M, HeL, JI M, QI Z. Synthesis fungicidalactivity and SAR of 3,4-dichloroisothiazolebasedcycloalkylsulfonamides. Bioorg Med Chem Lett. 2019;29(11):1345-49. doi: 10.1016/j.bmcl.2019.03.047, PMID30956010.21.Султонов, С. А. У., & Саноев, З. И. (2024). Оценка нейротропной активности синтетических гетероциклических соединений (обзор литературы). Re-health journal, (4 (24)), 33-38.22.Sanoev, Z. I., & Mirzaev, Y. R. (2020). Pharmacological activity of the possessingnew atypical neuroleptics 1-phenyltetrahydroisoquinoline structure. The American Journal of Medical Sciences and Pharmaceutical Research, 18-26.23.Sanoev, Z. I., & Mirzaev, Y. R. (2021). Research of a New Atypical Neuroleptic 1-(3, 4-Methylenedioxyphenyl)-6, 7-Methylenedioxy-1, 2, 3, 4-Tetrahydroisoquinoline on the Central Nervous System. Annals of the Romanian Society for Cell Biology, 25(2), 2363-2369.24.Turan Zitouni G, Sivaci M, Kilic FS, Erol K. Synthesis of sometriazolyl-antipyrine derivatives and investigation of analgesicactivity. Eur J Med Chem. 2001 Aug 1;36(7-8):685-9. doi:10.1016/s0223-5234(01)01252-1, PMID 11600237.25.Bekircan O, Kuxuk M, Kahveci B, Kolayli S. Convenient synthesisof fused heterocyclic 1,3,5-triazines from some N-acyl imidatesand heterocyclic amines as anticancer and antioxidant agents.Arch Pharm Int. 2005 Aug;338(8):365-72. doi:10.1002/ardp.200400964, PMID 16041836.26.Wade PC, Vogt BR, Kissick TP, Simpkins LM, Palmer DM, MillonigRC. 1-Acyltriazoles as antiinflammatory agents. J Med Chem.1982 Mar;25(3):331-3. doi: 10.1021/jm00345a021, PMID6461764.27.Mahdavi M, Akbarzadeh T, Sheibani V, Abbasi M, Firoozpour L,Tabatabai SA. Synthesis of two novel 3-amino-5-[4-chloro-2-phenoxyphenyl]-4H-1,2,4-triazoles with anticonvulsant activity.Iran J Pharm Res. 2010;9(3):265-9. PMID 24363736.28.Modzelewska Banachiewicz B, Kalabun J. Synthesis andbiological action of 5-oxo-1,2,4-triazine derivatives. Pharmazie.1999 Jul 1;54(7):503-5. PMID 10445245.29.Gupta D, Jain DK. Synthesis antifungal and antibacterial activityof novel 1,2,4-triazole derivatives. J Adv Pharm Technol Res.2015 Jul 1;6(3):141-6. doi: 10.4103/2231-4040.161515, PMID26317080.30.Gao F, Wang T, Xiao J, Huang G. Antibacterial activity study of1,2,4-triazole derivatives. Eur J Med Chem. 2019 Jul 1;173:274-81. doi: 10.1016/j.ejmech.2019.04.043, PMID 31009913.31.Gulerman N, Rollas S, Kiraz M, Ekinci AC, Vidin A. Evaluation ofantimycobacterial and anticonvulsant activities of new 1-(4-fluorobenzoyl)-4-substituted thiosemicarbazide and 5-(4-fluorophenyl)-4-substituted-2,4-dihydro-3H-1,2,4-triazole-3-thione derivatives. Farmaco. 1997 Nov 1;52(11):691-5. PMID9550096.32.Ikizler AA, Johansson CB, Bekircan O, Celik C. Drug synthesis.Acta Poloniae Pharnaceutica–Drug Research. 1999;56(4):283-8.33.Shalini M, Yogeeswari P, Sriram D, Stables JP. Cyclization of thesemicarbazone template of aryl semicarbazones: synthesis andanticonvulsant activity of 4,5-diphenyl-2H-1,2,4-triazol-3(4H)one. Biomed Pharmacother. 2009 Mar 1;63(3):187-93. doi:10.1016/j.biopha.2006.04.002, PMID 19422088.34.Siddiqui N, Ahsan W. Triazole incorporated thiazoles as a newclass of anticonvulsants: design, synthesis and in vivo screening.Eur J Med Chem. 2010 Apr 1;45(4):1536-43. doi:10.1016/j.ejmech.2009.12.062, PMID 20116140.35.Almasirad A, Tabatabai SA, Faizi M, Kebriaeezadeh A, Mehrabi N,Dalvandi A. Synthesis and anticonvulsant activity of new 2-substituted-5-[2-(2-fluorophenoxy)phenyl]-1,3,4-oxadiazolesand 1,2,4-triazoles. Bioorg Med ChemLett. 2004 Dec20;14(24):6057-9. doi: 10.1016/j.bmcl.2004.09.072, PMID15546729.
Кутилмоқда